314 related articles for article (PubMed ID: 30608640)
1. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
5. The importance of viral and cellular factors on flavivirus entry.
Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches to flavivirus drug discovery.
Botting C; Kuhn RJ
Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening.
Dai S; Zhang Y; Zhang T; Zhang B; Wang H; Deng F
Viruses; 2018 Jul; 10(7):. PubMed ID: 29997331
[TBL] [Abstract][Full Text] [Related]
8. Cellular Targets for the Treatment of Flavivirus Infections.
Zakaria MK; Carletti T; Marcello A
Front Cell Infect Microbiol; 2018; 8():398. PubMed ID: 30483483
[TBL] [Abstract][Full Text] [Related]
9. Favipiravir inhibits in vitro Usutu virus replication and delays disease progression in an infection model in mice.
Segura Guerrero NA; Sharma S; Neyts J; Kaptein SJF
Antiviral Res; 2018 Dec; 160():137-142. PubMed ID: 30385306
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein.
Sharma N; Prosser O; Kumar P; Tuplin A; Giri R
Antiviral Res; 2020 Oct; 182():104876. PubMed ID: 32783901
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.
Boldescu V; Behnam MAM; Vasilakis N; Klein CD
Nat Rev Drug Discov; 2017 Aug; 16(8):565-586. PubMed ID: 28473729
[TBL] [Abstract][Full Text] [Related]
12. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule inhibitors targeting the Zika virus envelope protein.
Pitts J; Hsia CY; Lian W; Wang J; Pfeil MP; Kwiatkowski N; Li Z; Jang J; Gray NS; Yang PL
Antiviral Res; 2019 Apr; 164():147-153. PubMed ID: 30771406
[TBL] [Abstract][Full Text] [Related]
14. Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses.
Carro SD; Cherry S
Viruses; 2020 Dec; 13(1):. PubMed ID: 33374822
[TBL] [Abstract][Full Text] [Related]
15. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609
[TBL] [Abstract][Full Text] [Related]
16. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of flavivirus membrane fusion.
Stiasny K; Fritz R; Pangerl K; Heinz FX
Amino Acids; 2011 Nov; 41(5):1159-63. PubMed ID: 19882217
[TBL] [Abstract][Full Text] [Related]
18. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
[TBL] [Abstract][Full Text] [Related]
19. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.
Felicetti T; Manfroni G; Cecchetti V; Cannalire R
ChemMedChem; 2020 Dec; 15(24):2391-2419. PubMed ID: 32961008
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.
Liu HY; Li Z; Reindl T; He Z; Qiu X; Golden RP; Donovan KA; Bailey A; Fischer ES; Zhang T; Gray NS; Yang PL
Nat Commun; 2024 Jun; 15(1):5179. PubMed ID: 38898037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
